ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Intelligence-driven Drug Development Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27K14354
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artificial Intelligence driven Drug Development Market Research Report 2023
BUY CHAPTERS

Global Artificial Intelligence-driven Drug Development Market Research Report 2025

Code: QYRE-Auto-27K14354
Report
May 2025
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
IBM
Exscientia Ltd
Google (Alphabet)
Microsoft
Atomwise
Schrodinger Llc
Aitia
InSilico Medicine
NVidia
XtalPi
BPGbio
OWKIN, Inc.
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica Inc
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals

Artificial Intelligence-driven Drug Development Market Size

The global market for Artificial Intelligence-driven Drug Development was valued at US$ 2280 million in the year 2024 and is projected to reach a revised size of US$ 14470 million by 2031, growing at a CAGR of 30.7% during the forecast period.

Artificial Intelligence-driven Drug Development Market

Artificial Intelligence-driven Drug Development Market

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
North American market for Artificial Intelligence-driven Drug Development is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Artificial Intelligence-driven Drug Development is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Artificial Intelligence-driven Drug Development in Early Drug Discovery is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Artificial Intelligence-driven Drug Development include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence-driven Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence-driven Drug Development.
The Artificial Intelligence-driven Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artificial Intelligence-driven Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence-driven Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Artificial Intelligence-driven Drug Development Market Report

Report Metric Details
Report Name Artificial Intelligence-driven Drug Development Market
Accounted market size in year US$ 2280 million
Forecasted market size in 2031 US$ 14470 million
CAGR 30.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hardware
  • Software
  • Service
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, BPGbio, Owkin, CytoReason, Deep Genomics, Cloud Pharmaceuticals, BenevolentAI, Cyclica, Verge Genomics, Valo Health, Envisagenics, Euretos, BioAge Labs, Iktos, BioSymetrics, Evaxion Biotech, Aria Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Artificial Intelligence-driven Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Artificial Intelligence-driven Drug Development Market growing?

Ans: The Artificial Intelligence-driven Drug Development Market witnessing a CAGR of 30.7% during the forecast period 2025-2031.

What is the Artificial Intelligence-driven Drug Development Market size in 2031?

Ans: The Artificial Intelligence-driven Drug Development Market size in 2031 will be US$ 14470 million.

Who are the main players in the Artificial Intelligence-driven Drug Development Market report?

Ans: The main players in the Artificial Intelligence-driven Drug Development Market are IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, BPGbio, Owkin, CytoReason, Deep Genomics, Cloud Pharmaceuticals, BenevolentAI, Cyclica, Verge Genomics, Valo Health, Envisagenics, Euretos, BioAge Labs, Iktos, BioSymetrics, Evaxion Biotech, Aria Pharmaceuticals

What are the Application segmentation covered in the Artificial Intelligence-driven Drug Development Market report?

Ans: The Applications covered in the Artificial Intelligence-driven Drug Development Market report are Early Drug Discovery, Preclinical Phase, Clinical Phase, Regulatory Approval

What are the Type segmentation covered in the Artificial Intelligence-driven Drug Development Market report?

Ans: The Types covered in the Artificial Intelligence-driven Drug Development Market report are Hardware, Software, Service

Recommended Reports

AI in Drug Discovery

AI Medical Diagnostics

AI in Medical Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence-driven Drug Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early Drug Discovery
1.3.3 Preclinical Phase
1.3.4 Clinical Phase
1.3.5 Regulatory Approval
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence-driven Drug Development Market Perspective (2020-2031)
2.2 Global Artificial Intelligence-driven Drug Development Growth Trends by Region
2.2.1 Global Artificial Intelligence-driven Drug Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Artificial Intelligence-driven Drug Development Historic Market Size by Region (2020-2025)
2.2.3 Artificial Intelligence-driven Drug Development Forecasted Market Size by Region (2026-2031)
2.3 Artificial Intelligence-driven Drug Development Market Dynamics
2.3.1 Artificial Intelligence-driven Drug Development Industry Trends
2.3.2 Artificial Intelligence-driven Drug Development Market Drivers
2.3.3 Artificial Intelligence-driven Drug Development Market Challenges
2.3.4 Artificial Intelligence-driven Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence-driven Drug Development Players by Revenue
3.1.1 Global Top Artificial Intelligence-driven Drug Development Players by Revenue (2020-2025)
3.1.2 Global Artificial Intelligence-driven Drug Development Revenue Market Share by Players (2020-2025)
3.2 Global Artificial Intelligence-driven Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence-driven Drug Development Revenue
3.4 Global Artificial Intelligence-driven Drug Development Market Concentration Ratio
3.4.1 Global Artificial Intelligence-driven Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence-driven Drug Development Revenue in 2024
3.5 Global Key Players of Artificial Intelligence-driven Drug Development Head office and Area Served
3.6 Global Key Players of Artificial Intelligence-driven Drug Development, Product and Application
3.7 Global Key Players of Artificial Intelligence-driven Drug Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence-driven Drug Development Breakdown Data by Type
4.1 Global Artificial Intelligence-driven Drug Development Historic Market Size by Type (2020-2025)
4.2 Global Artificial Intelligence-driven Drug Development Forecasted Market Size by Type (2026-2031)
5 Artificial Intelligence-driven Drug Development Breakdown Data by Application
5.1 Global Artificial Intelligence-driven Drug Development Historic Market Size by Application (2020-2025)
5.2 Global Artificial Intelligence-driven Drug Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Artificial Intelligence-driven Drug Development Market Size (2020-2031)
6.2 North America Artificial Intelligence-driven Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025)
6.4 North America Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence-driven Drug Development Market Size (2020-2031)
7.2 Europe Artificial Intelligence-driven Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025)
7.4 Europe Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence-driven Drug Development Market Size (2020-2031)
8.2 Asia-Pacific Artificial Intelligence-driven Drug Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025)
8.4 Asia-Pacific Artificial Intelligence-driven Drug Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence-driven Drug Development Market Size (2020-2031)
9.2 Latin America Artificial Intelligence-driven Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025)
9.4 Latin America Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size (2020-2031)
10.2 Middle East & Africa Artificial Intelligence-driven Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025)
10.4 Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence-driven Drug Development Introduction
11.1.4 IBM Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.1.5 IBM Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Details
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Artificial Intelligence-driven Drug Development Introduction
11.2.4 Exscientia Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.2.5 Exscientia Recent Development
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Details
11.3.2 Google(Alphabet) Business Overview
11.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Introduction
11.3.4 Google(Alphabet) Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.3.5 Google(Alphabet) Recent Development
11.4 Microsoft
11.4.1 Microsoft Company Details
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence-driven Drug Development Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.4.5 Microsoft Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Details
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence-driven Drug Development Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.5.5 Atomwise Recent Development
11.6 Schrodinger
11.6.1 Schrodinger Company Details
11.6.2 Schrodinger Business Overview
11.6.3 Schrodinger Artificial Intelligence-driven Drug Development Introduction
11.6.4 Schrodinger Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.6.5 Schrodinger Recent Development
11.7 Aitia
11.7.1 Aitia Company Details
11.7.2 Aitia Business Overview
11.7.3 Aitia Artificial Intelligence-driven Drug Development Introduction
11.7.4 Aitia Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.7.5 Aitia Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.8.5 Insilico Medicine Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Details
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Artificial Intelligence-driven Drug Development Introduction
11.9.4 NVIDIA Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.9.5 NVIDIA Recent Development
11.10 XtalPi
11.10.1 XtalPi Company Details
11.10.2 XtalPi Business Overview
11.10.3 XtalPi Artificial Intelligence-driven Drug Development Introduction
11.10.4 XtalPi Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.10.5 XtalPi Recent Development
11.11 BPGbio
11.11.1 BPGbio Company Details
11.11.2 BPGbio Business Overview
11.11.3 BPGbio Artificial Intelligence-driven Drug Development Introduction
11.11.4 BPGbio Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.11.5 BPGbio Recent Development
11.12 Owkin
11.12.1 Owkin Company Details
11.12.2 Owkin Business Overview
11.12.3 Owkin Artificial Intelligence-driven Drug Development Introduction
11.12.4 Owkin Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.12.5 Owkin Recent Development
11.13 CytoReason
11.13.1 CytoReason Company Details
11.13.2 CytoReason Business Overview
11.13.3 CytoReason Artificial Intelligence-driven Drug Development Introduction
11.13.4 CytoReason Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.13.5 CytoReason Recent Development
11.14 Deep Genomics
11.14.1 Deep Genomics Company Details
11.14.2 Deep Genomics Business Overview
11.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Introduction
11.14.4 Deep Genomics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.14.5 Deep Genomics Recent Development
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Details
11.15.2 Cloud Pharmaceuticals Business Overview
11.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Introduction
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.15.5 Cloud Pharmaceuticals Recent Development
11.16 BenevolentAI
11.16.1 BenevolentAI Company Details
11.16.2 BenevolentAI Business Overview
11.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Introduction
11.16.4 BenevolentAI Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.16.5 BenevolentAI Recent Development
11.17 Cyclica
11.17.1 Cyclica Company Details
11.17.2 Cyclica Business Overview
11.17.3 Cyclica Artificial Intelligence-driven Drug Development Introduction
11.17.4 Cyclica Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.17.5 Cyclica Recent Development
11.18 Verge Genomics
11.18.1 Verge Genomics Company Details
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Introduction
11.18.4 Verge Genomics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.18.5 Verge Genomics Recent Development
11.19 Valo Health
11.19.1 Valo Health Company Details
11.19.2 Valo Health Business Overview
11.19.3 Valo Health Artificial Intelligence-driven Drug Development Introduction
11.19.4 Valo Health Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.19.5 Valo Health Recent Development
11.20 Envisagenics
11.20.1 Envisagenics Company Details
11.20.2 Envisagenics Business Overview
11.20.3 Envisagenics Artificial Intelligence-driven Drug Development Introduction
11.20.4 Envisagenics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.20.5 Envisagenics Recent Development
11.21 Euretos
11.21.1 Euretos Company Details
11.21.2 Euretos Business Overview
11.21.3 Euretos Artificial Intelligence-driven Drug Development Introduction
11.21.4 Euretos Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.21.5 Euretos Recent Development
11.22 BioAge Labs
11.22.1 BioAge Labs Company Details
11.22.2 BioAge Labs Business Overview
11.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Introduction
11.22.4 BioAge Labs Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.22.5 BioAge Labs Recent Development
11.23 Iktos
11.23.1 Iktos Company Details
11.23.2 Iktos Business Overview
11.23.3 Iktos Artificial Intelligence-driven Drug Development Introduction
11.23.4 Iktos Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.23.5 Iktos Recent Development
11.24 BioSymetrics
11.24.1 BioSymetrics Company Details
11.24.2 BioSymetrics Business Overview
11.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Introduction
11.24.4 BioSymetrics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.24.5 BioSymetrics Recent Development
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Details
11.25.2 Evaxion Biotech Business Overview
11.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Introduction
11.25.4 Evaxion Biotech Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.25.5 Evaxion Biotech Recent Development
11.26 Aria Pharmaceuticals
11.26.1 Aria Pharmaceuticals Company Details
11.26.2 Aria Pharmaceuticals Business Overview
11.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Introduction
11.26.4 Aria Pharmaceuticals Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025)
11.26.5 Aria Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
IBM
Exscientia Ltd
Google (Alphabet)
Microsoft
Atomwise
Schrodinger Llc
Aitia
InSilico Medicine
NVidia
XtalPi
BPGbio
OWKIN, Inc.
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica Inc
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals
List of Tables
 Table 1. Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hardware
 Table 3. Key Players of Software
 Table 4. Key Players of Service
 Table 5. Global Artificial Intelligence-driven Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Artificial Intelligence-driven Drug Development Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Artificial Intelligence-driven Drug Development Market Share by Region (2020-2025)
 Table 9. Global Artificial Intelligence-driven Drug Development Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Artificial Intelligence-driven Drug Development Market Share by Region (2026-2031)
 Table 11. Artificial Intelligence-driven Drug Development Market Trends
 Table 12. Artificial Intelligence-driven Drug Development Market Drivers
 Table 13. Artificial Intelligence-driven Drug Development Market Challenges
 Table 14. Artificial Intelligence-driven Drug Development Market Restraints
 Table 15. Global Artificial Intelligence-driven Drug Development Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Artificial Intelligence-driven Drug Development Market Share by Players (2020-2025)
 Table 17. Global Top Artificial Intelligence-driven Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence-driven Drug Development as of 2024)
 Table 18. Ranking of Global Top Artificial Intelligence-driven Drug Development Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Artificial Intelligence-driven Drug Development Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Artificial Intelligence-driven Drug Development, Headquarters and Area Served
 Table 21. Global Key Players of Artificial Intelligence-driven Drug Development, Product and Application
 Table 22. Global Key Players of Artificial Intelligence-driven Drug Development, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Artificial Intelligence-driven Drug Development Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Type (2020-2025)
 Table 26. Global Artificial Intelligence-driven Drug Development Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Type (2026-2031)
 Table 28. Global Artificial Intelligence-driven Drug Development Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Application (2020-2025)
 Table 30. Global Artificial Intelligence-driven Drug Development Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Artificial Intelligence-driven Drug Development Revenue Market Share by Application (2026-2031)
 Table 32. North America Artificial Intelligence-driven Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Artificial Intelligence-driven Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Artificial Intelligence-driven Drug Development Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Artificial Intelligence-driven Drug Development Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Artificial Intelligence-driven Drug Development Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Artificial Intelligence-driven Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 47. IBM Company Details
 Table 48. IBM Business Overview
 Table 49. IBM Artificial Intelligence-driven Drug Development Product
 Table 50. IBM Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 51. IBM Recent Development
 Table 52. Exscientia Company Details
 Table 53. Exscientia Business Overview
 Table 54. Exscientia Artificial Intelligence-driven Drug Development Product
 Table 55. Exscientia Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 56. Exscientia Recent Development
 Table 57. Google(Alphabet) Company Details
 Table 58. Google(Alphabet) Business Overview
 Table 59. Google(Alphabet) Artificial Intelligence-driven Drug Development Product
 Table 60. Google(Alphabet) Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 61. Google(Alphabet) Recent Development
 Table 62. Microsoft Company Details
 Table 63. Microsoft Business Overview
 Table 64. Microsoft Artificial Intelligence-driven Drug Development Product
 Table 65. Microsoft Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 66. Microsoft Recent Development
 Table 67. Atomwise Company Details
 Table 68. Atomwise Business Overview
 Table 69. Atomwise Artificial Intelligence-driven Drug Development Product
 Table 70. Atomwise Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 71. Atomwise Recent Development
 Table 72. Schrodinger Company Details
 Table 73. Schrodinger Business Overview
 Table 74. Schrodinger Artificial Intelligence-driven Drug Development Product
 Table 75. Schrodinger Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 76. Schrodinger Recent Development
 Table 77. Aitia Company Details
 Table 78. Aitia Business Overview
 Table 79. Aitia Artificial Intelligence-driven Drug Development Product
 Table 80. Aitia Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 81. Aitia Recent Development
 Table 82. Insilico Medicine Company Details
 Table 83. Insilico Medicine Business Overview
 Table 84. Insilico Medicine Artificial Intelligence-driven Drug Development Product
 Table 85. Insilico Medicine Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 86. Insilico Medicine Recent Development
 Table 87. NVIDIA Company Details
 Table 88. NVIDIA Business Overview
 Table 89. NVIDIA Artificial Intelligence-driven Drug Development Product
 Table 90. NVIDIA Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 91. NVIDIA Recent Development
 Table 92. XtalPi Company Details
 Table 93. XtalPi Business Overview
 Table 94. XtalPi Artificial Intelligence-driven Drug Development Product
 Table 95. XtalPi Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 96. XtalPi Recent Development
 Table 97. BPGbio Company Details
 Table 98. BPGbio Business Overview
 Table 99. BPGbio Artificial Intelligence-driven Drug Development Product
 Table 100. BPGbio Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 101. BPGbio Recent Development
 Table 102. Owkin Company Details
 Table 103. Owkin Business Overview
 Table 104. Owkin Artificial Intelligence-driven Drug Development Product
 Table 105. Owkin Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 106. Owkin Recent Development
 Table 107. CytoReason Company Details
 Table 108. CytoReason Business Overview
 Table 109. CytoReason Artificial Intelligence-driven Drug Development Product
 Table 110. CytoReason Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 111. CytoReason Recent Development
 Table 112. Deep Genomics Company Details
 Table 113. Deep Genomics Business Overview
 Table 114. Deep Genomics Artificial Intelligence-driven Drug Development Product
 Table 115. Deep Genomics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 116. Deep Genomics Recent Development
 Table 117. Cloud Pharmaceuticals Company Details
 Table 118. Cloud Pharmaceuticals Business Overview
 Table 119. Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product
 Table 120. Cloud Pharmaceuticals Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 121. Cloud Pharmaceuticals Recent Development
 Table 122. BenevolentAI Company Details
 Table 123. BenevolentAI Business Overview
 Table 124. BenevolentAI Artificial Intelligence-driven Drug Development Product
 Table 125. BenevolentAI Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 126. BenevolentAI Recent Development
 Table 127. Cyclica Company Details
 Table 128. Cyclica Business Overview
 Table 129. Cyclica Artificial Intelligence-driven Drug Development Product
 Table 130. Cyclica Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 131. Cyclica Recent Development
 Table 132. Verge Genomics Company Details
 Table 133. Verge Genomics Business Overview
 Table 134. Verge Genomics Artificial Intelligence-driven Drug Development Product
 Table 135. Verge Genomics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 136. Verge Genomics Recent Development
 Table 137. Valo Health Company Details
 Table 138. Valo Health Business Overview
 Table 139. Valo Health Artificial Intelligence-driven Drug Development Product
 Table 140. Valo Health Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 141. Valo Health Recent Development
 Table 142. Envisagenics Company Details
 Table 143. Envisagenics Business Overview
 Table 144. Envisagenics Artificial Intelligence-driven Drug Development Product
 Table 145. Envisagenics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 146. Envisagenics Recent Development
 Table 147. Euretos Company Details
 Table 148. Euretos Business Overview
 Table 149. Euretos Artificial Intelligence-driven Drug Development Product
 Table 150. Euretos Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 151. Euretos Recent Development
 Table 152. BioAge Labs Company Details
 Table 153. BioAge Labs Business Overview
 Table 154. BioAge Labs Artificial Intelligence-driven Drug Development Product
 Table 155. BioAge Labs Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 156. BioAge Labs Recent Development
 Table 157. Iktos Company Details
 Table 158. Iktos Business Overview
 Table 159. Iktos Artificial Intelligence-driven Drug Development Product
 Table 160. Iktos Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 161. Iktos Recent Development
 Table 162. BioSymetrics Company Details
 Table 163. BioSymetrics Business Overview
 Table 164. BioSymetrics Artificial Intelligence-driven Drug Development Product
 Table 165. BioSymetrics Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 166. BioSymetrics Recent Development
 Table 167. Evaxion Biotech Company Details
 Table 168. Evaxion Biotech Business Overview
 Table 169. Evaxion Biotech Artificial Intelligence-driven Drug Development Product
 Table 170. Evaxion Biotech Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 171. Evaxion Biotech Recent Development
 Table 172. Aria Pharmaceuticals Company Details
 Table 173. Aria Pharmaceuticals Business Overview
 Table 174. Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product
 Table 175. Aria Pharmaceuticals Revenue in Artificial Intelligence-driven Drug Development Business (2020-2025) & (US$ Million)
 Table 176. Aria Pharmaceuticals Recent Development
 Table 177. Research Programs/Design for This Report
 Table 178. Key Data Information from Secondary Sources
 Table 179. Key Data Information from Primary Sources
 Table 180. Authors List of This Report


List of Figures
 Figure 1. Artificial Intelligence-driven Drug Development Picture
 Figure 2. Global Artificial Intelligence-driven Drug Development Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Artificial Intelligence-driven Drug Development Market Share by Type: 2024 VS 2031
 Figure 4. Hardware Features
 Figure 5. Software Features
 Figure 6. Service Features
 Figure 7. Global Artificial Intelligence-driven Drug Development Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Artificial Intelligence-driven Drug Development Market Share by Application: 2024 VS 2031
 Figure 9. Early Drug Discovery Case Studies
 Figure 10. Preclinical Phase Case Studies
 Figure 11. Clinical Phase Case Studies
 Figure 12. Regulatory Approval Case Studies
 Figure 13. Artificial Intelligence-driven Drug Development Report Years Considered
 Figure 14. Global Artificial Intelligence-driven Drug Development Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Artificial Intelligence-driven Drug Development Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Artificial Intelligence-driven Drug Development Market Share by Region: 2024 VS 2031
 Figure 17. Global Artificial Intelligence-driven Drug Development Market Share by Players in 2024
 Figure 18. Global Top Artificial Intelligence-driven Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence-driven Drug Development as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Artificial Intelligence-driven Drug Development Revenue in 2024
 Figure 20. North America Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Artificial Intelligence-driven Drug Development Market Share by Country (2020-2031)
 Figure 22. United States Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Artificial Intelligence-driven Drug Development Market Share by Country (2020-2031)
 Figure 26. Germany Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Artificial Intelligence-driven Drug Development Market Share by Region (2020-2031)
 Figure 34. China Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Artificial Intelligence-driven Drug Development Market Share by Country (2020-2031)
 Figure 42. Mexico Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Artificial Intelligence-driven Drug Development Market Share by Country (2020-2031)
 Figure 46. Turkey Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Artificial Intelligence-driven Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. IBM Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 50. Exscientia Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 51. Google(Alphabet) Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 52. Microsoft Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 53. Atomwise Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 54. Schrodinger Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 55. Aitia Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 56. Insilico Medicine Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 57. NVIDIA Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 58. XtalPi Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 59. BPGbio Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 60. Owkin Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 61. CytoReason Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 62. Deep Genomics Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 63. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 64. BenevolentAI Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 65. Cyclica Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 66. Verge Genomics Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 67. Valo Health Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 68. Envisagenics Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 69. Euretos Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 70. BioAge Labs Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 71. Iktos Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 72. BioSymetrics Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 73. Evaxion Biotech Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 74. Aria Pharmaceuticals Revenue Growth Rate in Artificial Intelligence-driven Drug Development Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

AI driven Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Intelligence Drug R D Market Research Report 2024
Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030
Global AI Technology in Pharmaceutical Market Research Report 2024
Artificial Intelligence in Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence For Drug Development and Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Developing Platforms by Artificial Intelligence AI Market Research Report 2024
Global AI for Drug Discovery and Development Market Research Report 2025
Global AI for Pharma and Biotech Market Insights Forecast to 2030
Artificial Intelligence AI in Biotechnology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI based Clinical Trials Solution Provider Market Research Report 2024
Artificial Intelligence AI in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intelligent Drug R D Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Machine Learning in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI based Antibody Development Platform Market Research Report 2024
AI assisted Drug Design AIDD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Intelligence Drug Development Market Research Report 2024
AI Drug Development Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence and Machine Learning Market
AI Drug Discovery Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions